Hyperprolactinaemia
Treatment of hyperprolactinaemia
Cabergoline
Cabergoline 500microgram tablets
To be initiated on specialist advice. See BNF for dose adjustment.
Quinagolide
Quinagolide 25microgram tablets
To be initiated on specialist advice. See BNF for dose adjustment.
Quinagolide 50microgram tablets
To be initiated on specialist advice. See BNF for dose adjustment.
Quinagolide 75microgram tablets
To be initiated on specialist advice. See BNF for dose adjustment.
Prescribing Notes:
- Bromocriptine is the treatment of choice for hyperprolactinaemia during pregnancy or those planning pregnancy.
- Cabergoline and bromocriptine are associated with a low risk of fibrotic disorders and heart valve damage associated with ergot-derived dopamine agonists. Periodic echocardiography is recommended.
- For suppression of lactation, see the Obstetrics, gynaecology, and urinary-tract disorders chapter of the formulary.
- For Parkinson’s disease, see the Central nervous system chapter of the formulary.
History Notes
16/02/2022
East Region Formulary content agreed.